Study: Risk of dying from cancer depends on where you live in England

The risk of dying from the 10 forms of cancer with the largest death toll for men and women varies massively depending on the district in England where people live, according to a study published in The Lancet Oncology.

Eckert & Ziegler Achieves European Approval for Theralugand® – Lutetium-177 Chloride (n.c.a) – Biotech Investments

EQS-News: Eckert & Ziegler SE / Key word(s): Regulatory Approval/Market Launch Eckert & Ziegler Achieves European Approval for Theralugand® – Lutetium-177 Chloride (n.c.a) 27.11.2024 /

November 28, 2024

‘Make Measles Great Again’; Docs Blast Super Bowl Ads; Big Food vs GLP-1 Drugs

The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. “Make measles great again,” surgeon David Gorski, MD, PhD,

February 14, 2025

Novartis’ Kisqali snags FDA approval to reduce recurrence in patients with early forms of breast cancer

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.